Hemlibra Patient assistance program
Complete a free online enrollment application to find out if you’re eligible to pay only $49 per month for your Hemlibra medication with our help.Get Started Now
Secure: Your personal and medical information is safe with us
Convenient: Your medication is delivered straight to your door
Ongoing refills: Your medication is refilled automatically
NiceRx works with your healthcare provider to help you access affordable medications directly from U.S. pharmaceutical companies.
How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are qualified. The pharmaceutical company provides your medication for free and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address.
Your monthly Hemlibra cost savings if eligible
The Hemlibra patient assistance program can provide your medication for free. We simply charge $49 per month for each medication to cover the cost of our services. With NiceRx, you will only pay $49 to obtain your Hemlibra, regardless of the retail price.
Am I eligible for the Hemlibra patient assistance program?
To find out if you are eligible for Hemlibra assistance you can apply online using our enrollment application. Each pharmaceutical company sets its eligibility criteria, and we will review your application individually to determine if you may be eligible. The three main factors to consider are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Hemlibra patient assistance program?
Our application process aims to make it as easy as possible to apply for the Hemlibra patient assistance program. The first step is to complete our online enrollment application. We will ask you for details about your healthcare provider, your insurance plan, and your household income as this information is required by the pharmaceutical companies. We may be able to help you apply for other patient assistance programs too, so be sure to tell us about any medications you are taking as well as Hemlibra.
NiceRx will review your application and determine whether you may be eligible for Hemlibra assistance. If so, we will handle the full enrollment process for you and prepare all required documents for your healthcare provider to sign. Once you are successfully enrolled in the Hemlibra patient assistance program, we will help you manage your prescription refills by requesting refills on your behalf throughout your enrollment period. At the end of your enrollment period, we will contact you for updated information and seek to re-enroll you so you can continue to access affordable Hemlibra.
Is NiceRx a Hemlibra coupons provider?
NiceRx is a service provider that helps eligible individuals access the Hemlibra patient assistance program. We do not offer trial offers or free Hemlibra samples. When obtaining your medication through NiceRx, you will only pay $49 a month per medication. This will likely save you more money than if you were to use Hemlibra coupons, discount cards, or Hemlibra copay cards.
Can NiceRx help me get Hemlibra if I have insurance?
NiceRx may be able to help you if your insurance company will not pay for your Hemlibra medication. We may also be able to help if you have a high copay or coinsurance responsibility. Whether you have insurance or not, apply online using our enrollment application to find out more.
How much does Hemlibra cost without insurance?
Hemlibra prices without insurance will vary depending on how much you buy. Prices will also vary by retailer. As a guide, Hemlibra subcutaneous solution (30 mg/mL) typically costs $3,200 for 1 milliliter.
How much does Hemlibra cost with insurance?
The copay for Hemlibra will vary by the terms of your healthcare plan. To find out what you might need to pay for Hemlibra with insurance, your insurance provider or pharmacist will be able to help you calculate the copay costs with your current insurance.
What is Hemlibra?
Hemlibra is an FDA (Food and Drug Administration) approved medication manufactured by Genentech, Inc.
Hemlibra is a bispecific factor IXa- and factor X-directed antibody used for routine prophylaxis to stop or reduce the number of bleeding episodes in adult and pediatric patients with hemophilia A (an inherited bleeding disorder caused by lack of factor VIII) with factor VIII inhibitors.
Cases of thrombotic microangiopathy (TMA) and thrombotic events (thromboembolism) were reported when on average a cumulative amount of >100 U/kg/24 hours of activated prothrombin complex concentrate (aPCC) was given for 24 hours or more, to patients receiving Hemlibra prophylaxis. Monitor for the development of thrombotic microangiopathy and thrombotic events if aPCC is given, but stop aPCC and dosing of Hemlibra if symptoms do occur.
What doses of Hemlibra are available?
Hemlibra is in injection form, in the following doses: 30 mg/mL in a single-dose vial, 60 mg/0.4 mL in a single-dose vial, 105 mg/0.7 mL in a single-dose vial, 150 mg/mL in a single-dose vial
The recommended loading dose is 3 mg/kg by subcutaneous injection once weekly for the first 4 weeks, followed by 1.5 mg/kg once weekly. A healthcare professional may teach you how to properly use the medication yourself. Keep this medicine in the original container in a refrigerator. Protect from light and do not freeze.
You will need a syringe and needle to draw Hemlibra out of the vial (bottle) and a separate needle to inject the medicine into your skin. Use only the type of syringe and needles recommended by your pharmacist to inject Hemlibra. Hemlibra can interfere with blood-clotting tests.
See full prescribing information for important preparation and administration instructions. Always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Hemlibra active ingredients
Hemlibra contains emicizumab which is classed as a monoclonal antibody.
Hemlibra side effects
The most common side effects of Hemlibra in clinical trials include:
- Injection site reactions
- Arthralgia – joint pain
In rare instances, Hemlibra can cause more serious side effects. These can include:
- Feeling weak or confused
- Little or no urination, back pain
- Vomiting, stomach pain
- Chest pain, feeling short of breath, coughing up blood
- Swelling or redness in your arms or legs
- Eye pain or swelling, problems with vision
- Face feels numb
- Yellowing of your skin or eyes
Your doctor will assess the benefits of using Hemlibra against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Hemlibra to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Hemlibra drug interactions
Hemlibra can interact with other medications. These include:
This list is not exhaustive and other drugs may interact with Hemlibra.
You should not use Hemlibra if you:
- Are allergic to the active ingredient emicizumab-kxwh
- Are allergic to any of the other ingredients in Hemlibra
- Are pregnant or are planning to become pregnant – women of childbearing potential should use contraception while receiving treatment. It is not known if Hemlibra will cause fetal harm. Controlling bleeding episodes is very important during pregnancy. The benefit of preventing these episodes may outweigh any risks to the baby.
Talk to your doctor before using Hemlibra if you:
- Are taking any of the medications that could interact with Hemlibra
- Are breastfeeding or are planning to breastfeed – it is not known if emicizumab passes into breast milk
- Use factor VIII or a bypassing agent such as FEIBA or aPCC (activated prothrombin complex concentrate). Emicizumab can cause unwanted blood clots when used together with aPCC. These blood clots can cause damage to small blood vessels in your arms and legs, brain, kidneys, lungs, or other organs. You will need to stop using your prophylactic bypassing agents the day before you start using Hemlibra. But you may keep using factor VIII for the first week of using Hemlibra
Hemlibra is the trademark brand name for emicizumab manufactured by Genentech, Inc. A generic version of emicizumab is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Hemlibra savings through NiceRx.
*Qualifying persons may obtain medications directly from patient assistance programs without any out-of-pocket cost (or for less than $49 per medication). However, our monthly flat rate of just $49 per medication spares you the hassle of tracking the different programs and filling out all the required paperwork for each program. Subject to medication availability.
Enrollees enjoy a full-service solution, as NiceRx assists them and their physicians with the entire process. We prepare all required documents for the physician to sign, help enrollees manage all prescription refills, monitor eligibility criteria, and maintain enrollment.
**If you do not receive medications because you were determined to be ineligible for the prescription assistance by the applicable pharmaceutical companies and you have a letter of denial, we will refund any fees you paid toward medications for which you did not qualify to receive prescription assistance (“Refund”).
To receive a refund, you must send the letter of denial to us by fax to 888-517-7444, or by e-mail to [email protected] within 30 days of your receipt of such letter. The Refund is your sole and exclusive remedy for any fees you may wish to dispute.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.